This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Want Better Returns? Don?t Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Want Better Returns? Don?t Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Bunge (BG) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Bunge (BG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bunge (BG) Inks Deal to Buy Fuji Oil's Refinery in Louisiana
by Zacks Equity Research
Bunge (BG) enters a definitive asset purchase agreement with Fuji Oil.
Time to Buy Cal-Maine Foods (CALM) Stock After Strong Earnings?
by Shaun Pruitt
Let's see if investors should buy into the rally with Cal-Maine stock up 9% following its stellar fiscal third-quarter results on Tuesday.
Bunge (BG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Bunge (BG) closed at $96.60, marking a +0.8% move from the previous day.
Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia Biosciences
by Zacks Equity Research
Bunge, CalMaine Foods and Arcadia Biosciences are part of the Zacks Industry Outlook article.
Bunge (BG) Stock Moves -1.6%: What You Should Know
by Zacks Equity Research
In the latest trading session, Bunge (BG) closed at $95.64, marking a -1.6% move from the previous day.
3 Stocks to Watch in the Promising Agriculture - Products Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Bunge (BG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bunge (BG) closed at $96.72 in the latest trading session, marking a -0.07% move from the prior day.
Bunge (BG) Ties with Corteva & Chevron to Make Winter Canola
by Zacks Equity Research
Bunge (BG) collaborates with Corteva and Chevron to produce winter canola hybrids and boost supply of vegetable oil feedstocks.
Company News for Mar 15, 2023
by Zacks Equity Research
Companies In The News Are: META, BG, SBNY, PFE, UAL.
Strength Seen in Bunge (BG): Can Its 14.5% Jump Turn into More Strength?
by Zacks Equity Research
Bunge (BG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Bunge (BG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Bunge (BG) closed at $94.91, marking a -1.97% move from the previous day.
Bunge (BG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Bunge (BG) closed the most recent trading day at $98.77, moving +1.24% from the previous trading session.
ETF Strategies to Protect Against Inflation
by Neena Mishra
Recent reports suggest inflation may remain elevated.
Are Investors Undervaluing Bunge Limited (BG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bunge Limited (BG) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Bunge Limited's (BG) fourth-quarter results are likely to reflect favorable markets in the Refined and Specialty Oils and the Milling segments.
Bunge (BG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
Wall Street Analysts Believe Bunge (BG) Could Rally 27.4%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 27.4% upside potential for Bunge (BG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Bunge (BG) Stock Moves -0.54%: What You Should Know
by Zacks Equity Research
Bunge (BG) closed at $97.07 in the latest trading session, marking a -0.54% move from the prior day.
Bunge (BG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Bunge (BG) closed at $96.88 in the latest trading session, marking a +0.32% move from the prior day.
Is Bunge Limited (BG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bunge (BG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Bunge (BG) closed the most recent trading day at $98.39, moving +0.51% from the previous trading session.
Bunge (BG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bunge (BG) closed at $97.51, marking a -0.54% move from the previous day.